Literature DB >> 28131816

TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.

Hiroyuki Yamamoto1, Joohyun Ryu1, Eli Min1, Naomi Oi1, Ruihua Bai1, Tatyana A Zykova1, Dong Hoon Yu1, Kenji Moriyama2, Ann M Bode1, Zigang Dong3.   

Abstract

TRAF1 is a member of the TRAF protein family, which regulates the canonical and noncanonical NF-κB signaling cascades. Although aberrant TRAF1 expression in tumors has been reported, the role of TRAF1 remains elusive. Here, we report that TRAF1 is required for solar UV-induced skin carcinogenesis. Immunohistochemical analysis showed that TRAF1 expression is up-regulated in human actinic keratosis and squamous cell carcinoma. In vivo studies indicated that TRAF1 expression levels in mouse skin are induced by short-term solar UV irradiation, and a long-term skin carcinogenesis study showed that deletion of TRAF1 in mice results in a significant inhibition of skin tumor formation. Moreover, we show that TRAF1 is required for solar UV-induced extracellular signal-regulated kinase-5 (ERK5) phosphorylation and the expression of AP-1 family members (c-Fos/c-Jun). Mechanistic studies showed that TRAF1 expression enhances the ubiquitination of ERK5 on lysine 184, which is necessary for its kinase activity and AP-1 activation. Overall, our results suggest that TRAF1 mediates ERK5 activity by regulating the upstream effectors of ERK5 and also by modulating its ubiquitination status. Targeting TRAF1 function might lead to strategies for preventing and treating skin cancer.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  12-O-tetradecanoylphorbol-13-acetate; 7,12-dimethylbenz[a]anthracene; AK; DMBA; ERK; ERK kinase 5; HA; HEK; HEKa; K; MAPK; MEK5; SCC; TPA; WT; actinic keratosis; adult human epidermal keratinocyte; extracellular signal-regulated protein kinase; hemagglutinin; human embryonic kidney; keratin; mitogen-activated protein kinase; squamous cell carcinoma; wild type

Mesh:

Substances:

Year:  2017        PMID: 28131816      PMCID: PMC5995119          DOI: 10.1016/j.jid.2016.12.026

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  46 in total

1.  Overexpression of goosecoid homeobox is associated with chemoresistance and poor prognosis in ovarian carcinoma.

Authors:  Kyong-Won Kang; Mi-Jung Lee; Ji-Ae Song; Ju-Yeon Jeong; Yoo-Kyong Kim; Chan Lee; Tae-Heon Kim; Kyu-Beom Kwak; Ok-Jun Kim; Hee Jung An
Journal:  Oncol Rep       Date:  2014-05-20       Impact factor: 3.906

2.  Activation of a C-terminal transcriptional activation domain of ERK5 by autophosphorylation.

Authors:  Hiroko Morimoto; Kunio Kondoh; Satoko Nishimoto; Kazuya Terasawa; Eisuke Nishida
Journal:  J Biol Chem       Date:  2007-10-10       Impact factor: 5.157

3.  Taxifolin suppresses UV-induced skin carcinogenesis by targeting EGFR and PI3K.

Authors:  Naomi Oi; Hanyong Chen; Myoung Ok Kim; Ronald A Lubet; Ann M Bode; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2012-07-17

4.  BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.

Authors:  Y Kato; V V Kravchenko; R I Tapping; J Han; R J Ulevitch; J D Lee
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

5.  Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes.

Authors:  Yoshikazu Nakaoka; Keigo Nishida; Yasushi Fujio; Masahiro Izumi; Kazuo Terai; Yuichi Oshima; Shoko Sugiyama; Satoshi Matsuda; Shigeo Koyasu; Keiko Yamauchi-Takihara; Toshio Hirano; Ichiro Kawase; Hisao Hirota
Journal:  Circ Res       Date:  2003-07-10       Impact factor: 17.367

6.  Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.

Authors:  S G Khan; R R Mohan; S K Katiyar; G S Wood; D R Bickers; H Mukhtar; R Agarwal
Journal:  Mol Carcinog       Date:  1996-02       Impact factor: 4.784

7.  TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.

Authors:  Feng Guo; Aining Sun; Wenjuan Wang; Jun He; Jianquan Hou; Peng Zhou; Zixing Chen
Journal:  Mol Immunol       Date:  2009-06-21       Impact factor: 4.407

8.  ERK5 activation is essential for osteoclast differentiation.

Authors:  Shigeru Amano; Yu-Tzu Chang; Yasuhisa Fukui
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

9.  Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.

Authors:  A E S Simões; D M Pereira; S E Gomes; H Brito; T Carvalho; A French; R E Castro; C J Steer; S N Thibodeau; C M P Rodrigues; P M Borralho
Journal:  Cell Death Dis       Date:  2015-04-09       Impact factor: 8.469

10.  AP1 transcription factors in epidermal differentiation and skin cancer.

Authors:  Richard L Eckert; Gautam Adhikary; Christina A Young; Ralph Jans; James F Crish; Wen Xu; Ellen A Rorke
Journal:  J Skin Cancer       Date:  2013-05-23
View more
  9 in total

1.  Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032.

Authors:  Eunmiri Roh; Yaping Han; Kanamata Reddy; Tatyana A Zykova; Mee Hyun Lee; Ke Yao; Ruihua Bai; Clara Curiel-Lewandrowski; Zigang Dong
Journal:  Oncogene       Date:  2020-04-10       Impact factor: 9.867

2.  CD40/TRAF1 decreases synovial cell apoptosis in patients with rheumatoid arthritis through JNK/NF-κB pathway.

Authors:  Tao Cheng; Jian Wu; Yaozeng Xu; Cuiping Liu; Huayong Zhang; Mingjun Wang
Journal:  J Bone Miner Metab       Date:  2022-08-12       Impact factor: 2.976

3.  N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma.

Authors:  Yuanlei Chen; Zeyi Lu; Chao Qi; Chenhao Yu; Yang Li; Wang Huan; Ruyue Wang; Wenqin Luo; Danyang Shen; Lifeng Ding; Liangliang Ren; Haiyun Xie; Dingwei Xue; Mingchao Wang; Kangxin Ni; Liqun Xia; Jun Qian; Gonghui Li
Journal:  Mol Cancer       Date:  2022-05-10       Impact factor: 41.444

Review 4.  Structural feature of TRAFs, their related human diseases and therapeutic intervention.

Authors:  Hyun Ho Park
Journal:  Arch Pharm Res       Date:  2021-05-10       Impact factor: 4.946

Review 5.  TRAF1 Signaling in Human Health and Disease.

Authors:  Maria I Edilova; Ali A Abdul-Sater; Tania H Watts
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

6.  Sublytic C5b-9 induces proliferation of glomerular mesangial cells via ERK5/MZF1/RGC-32 axis activated by FBXO28-TRAF6 complex.

Authors:  Tianyi Yu; Lulu Wang; Chenhui Zhao; Baomei Qian; Chunlei Yao; Fengxia He; Yufeng Zhu; Mengyuan Cai; Mei Li; Dan Zhao; Jing Zhang; Yingwei Wang; Wen Qiu
Journal:  J Cell Mol Med       Date:  2019-06-11       Impact factor: 5.310

7.  DNMT1-induced miR-378a-3p silencing promotes angiogenesis via the NF-κB signaling pathway by targeting TRAF1 in hepatocellular carcinoma.

Authors:  Bin Zhu; Jun-Jie Chen; Ying Feng; Jun-Ling Yang; Hua Huang; Wen Yuan Chung; Yi-Lin Hu; Wan-Jiang Xue
Journal:  J Exp Clin Cancer Res       Date:  2021-11-08

Review 8.  Genetic Alterations of TRAF Proteins in Human Cancers.

Authors:  Sining Zhu; Juan Jin; Samantha Gokhale; Angeli M Lu; Haiyan Shan; Jianjun Feng; Ping Xie
Journal:  Front Immunol       Date:  2018-09-20       Impact factor: 7.561

9.  TRAF1 suppresses antifungal immunity through CXCL1-mediated neutrophil recruitment during Candida albicans intradermal infection.

Authors:  Wenjuan Bai; Qingqing Wang; Zihou Deng; Tiantian Li; Hui Xiao; Zhiyuan Wu
Journal:  Cell Commun Signal       Date:  2020-02-24       Impact factor: 5.712

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.